241 related articles for article (PubMed ID: 31961914)
1. CFTR dysregulation drives active selection of the gut microbiome.
Meeker SM; Mears KS; Sangwan N; Brittnacher MJ; Weiss EJ; Treuting PM; Tolley N; Pope CE; Hager KR; Vo AT; Paik J; Frevert CW; Hayden HS; Hoffman LR; Miller SI; Hajjar AM
PLoS Pathog; 2020 Jan; 16(1):e1008251. PubMed ID: 31961914
[TBL] [Abstract][Full Text] [Related]
2. Cystic fibrosis mouse model-dependent intestinal structure and gut microbiome.
Bazett M; Honeyman L; Stefanov AN; Pope CE; Hoffman LR; Haston CK
Mamm Genome; 2015 Jun; 26(5-6):222-34. PubMed ID: 25721416
[TBL] [Abstract][Full Text] [Related]
3. Fecal dysbiosis and inflammation in intestinal-specific Cftr knockout mice on regimens preventing intestinal obstruction.
Young SM; Woode RA; Williams EC; Ericsson AC; Clarke LL
Physiol Genomics; 2024 Mar; 56(3):247-264. PubMed ID: 38073491
[TBL] [Abstract][Full Text] [Related]
4. The Intestinal Microbiome and Cystic Fibrosis Transmembrane Conductance Regulator Modulators: Emerging Themes in the Management of Gastrointestinal Manifestations of Cystic Fibrosis.
Karb DB; Cummings LC
Curr Gastroenterol Rep; 2021 Aug; 23(10):17. PubMed ID: 34448955
[TBL] [Abstract][Full Text] [Related]
5. Lung and Gut Microbiota Changes Associated with
Bacci G; Rossi A; Armanini F; Cangioli L; De Fino I; Segata N; Mengoni A; Bragonzi A; Bevivino A
Int J Mol Sci; 2021 Nov; 22(22):. PubMed ID: 34830048
[TBL] [Abstract][Full Text] [Related]
6. Cftr deletion in mouse epithelial and immune cells differentially influence the intestinal microbiota.
Scull CE; Luo M; Jennings S; Taylor CM; Wang G
Commun Biol; 2022 Oct; 5(1):1130. PubMed ID: 36289287
[TBL] [Abstract][Full Text] [Related]
7. Gut microbiota signatures in cystic fibrosis: Loss of host CFTR function drives the microbiota enterophenotype.
Vernocchi P; Del Chierico F; Russo A; Majo F; Rossitto M; Valerio M; Casadei L; La Storia A; De Filippis F; Rizzo C; Manetti C; Paci P; Ercolini D; Marini F; Fiscarelli EV; Dallapiccola B; Lucidi V; Miccheli A; Putignani L
PLoS One; 2018; 13(12):e0208171. PubMed ID: 30521551
[TBL] [Abstract][Full Text] [Related]
8. Impact of CFTR modulation with Ivacaftor on Gut Microbiota and Intestinal Inflammation.
Ooi CY; Syed SA; Rossi L; Garg M; Needham B; Avolio J; Young K; Surette MG; Gonska T
Sci Rep; 2018 Dec; 8(1):17834. PubMed ID: 30546102
[TBL] [Abstract][Full Text] [Related]
9. Cystic Fibrosis, CFTR, and Colorectal Cancer.
Scott P; Anderson K; Singhania M; Cormier R
Int J Mol Sci; 2020 Apr; 21(8):. PubMed ID: 32326161
[TBL] [Abstract][Full Text] [Related]
10. Cystic fibrosis transmembrane conductance regulator knockout mice exhibit aberrant gastrointestinal microbiota.
Lynch SV; Goldfarb KC; Wild YK; Kong W; De Lisle RC; Brodie EL
Gut Microbes; 2013; 4(1):41-7. PubMed ID: 23060053
[TBL] [Abstract][Full Text] [Related]
11. Streptomycin treatment alters the intestinal microbiome, pulmonary T cell profile and airway hyperresponsiveness in a cystic fibrosis mouse model.
Bazett M; Bergeron ME; Haston CK
Sci Rep; 2016 Jan; 6():19189. PubMed ID: 26754178
[TBL] [Abstract][Full Text] [Related]
12. The Microbiome in Cystic Fibrosis Pulmonary Disease.
Françoise A; Héry-Arnaud G
Genes (Basel); 2020 May; 11(5):. PubMed ID: 32403302
[TBL] [Abstract][Full Text] [Related]
13. Cystic Fibrosis-Related Gut Dysbiosis: A Systematic Review.
Caley LR; White H; de Goffau MC; Floto RA; Parkhill J; Marsland B; Peckham DG
Dig Dis Sci; 2023 May; 68(5):1797-1814. PubMed ID: 36600119
[TBL] [Abstract][Full Text] [Related]
14. Fecal dysbiosis in infants with cystic fibrosis is associated with early linear growth failure.
Hayden HS; Eng A; Pope CE; Brittnacher MJ; Vo AT; Weiss EJ; Hager KR; Martin BD; Leung DH; Heltshe SL; Borenstein E; Miller SI; Hoffman LR
Nat Med; 2020 Feb; 26(2):215-221. PubMed ID: 31959989
[TBL] [Abstract][Full Text] [Related]
15. Optimal complement-mediated phagocytosis of Pseudomonas aeruginosa by monocytes is cystic fibrosis transmembrane conductance regulator-dependent.
Van de Weert-van Leeuwen PB; Van Meegen MA; Speirs JJ; Pals DJ; Rooijakkers SH; Van der Ent CK; Terheggen-Lagro SW; Arets HG; Beekman JM
Am J Respir Cell Mol Biol; 2013 Sep; 49(3):463-70. PubMed ID: 23617438
[TBL] [Abstract][Full Text] [Related]
16. Metagenomic evidence for taxonomic dysbiosis and functional imbalance in the gastrointestinal tracts of children with cystic fibrosis.
Manor O; Levy R; Pope CE; Hayden HS; Brittnacher MJ; Carr R; Radey MC; Hager KR; Heltshe SL; Ramsey BW; Miller SI; Hoffman LR; Borenstein E
Sci Rep; 2016 Mar; 6():22493. PubMed ID: 26940651
[TBL] [Abstract][Full Text] [Related]
17. Traumatic Brain Injury in Mice Induces Acute Bacterial Dysbiosis Within the Fecal Microbiome.
Treangen TJ; Wagner J; Burns MP; Villapol S
Front Immunol; 2018; 9():2757. PubMed ID: 30546361
[TBL] [Abstract][Full Text] [Related]
18. Iron Homeostasis and Inflammatory Status in Mice Deficient for the Cystic Fibrosis Transmembrane Regulator.
Deschemin JC; Allouche S; Brouillard F; Vaulont S
PLoS One; 2015; 10(12):e0145685. PubMed ID: 26709821
[TBL] [Abstract][Full Text] [Related]
19. The cystic fibrosis intestine.
De Lisle RC; Borowitz D
Cold Spring Harb Perspect Med; 2013 Sep; 3(9):a009753. PubMed ID: 23788646
[TBL] [Abstract][Full Text] [Related]
20. Neonatal Gastrointestinal and Respiratory Microbiome in Cystic Fibrosis: Potential Interactions and Implications for Systemic Health.
Madan JC
Clin Ther; 2016 Apr; 38(4):740-6. PubMed ID: 26973296
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
